-
How Will the Transition to hs-cTn Affect the Diagnosis of Type 1 and 2 MI?Y Sandoval; FS Apple; AS Jaffe -
Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or with Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights from the AUGUSTUS TrialS Windecker , RD Lopes, AUGUSTUS Investigators et al.
-
Relationship Between Infarct Size and Outcomes Following Primary PCI: Patient-Level Analysis From 10 Randomized TrialsStone GW, Selker HP, Thiele H et al.
-
A Randomized Trial of a 1-Hour Troponin T Protocol in Suspected Acute Coronary Syndromes: The Rapid Assessment of Possible ACS In the Emergency Department with High Sensitivity Troponin T (RAPID-TnT) StudyDP Chew, K Lambrakis, A Blyth et al.
-
Fourth Universal Definition of Myocardial Infarction (2018)Thygesen K, Alpert JS, Executive Group on behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction.
-
Investigating methotrexate toxicity within a randomized double-blinded, placebo-controlled trial: Rationale and design of the Cardiovascular Inflammation Reduction Trial-Adverse Events (CIRT-AE) StudySparks JA, Barbhaiya M, Karlson EW et al.
-
National assessment of early β-blocker therapy in patients with acute myocardial infarction in China, 2001-2011: The China Patient-centered Evaluative Assessment of Cardiac Events (PEACE)-Retrospective AMI StudyZhang H, Jiang L, China PEACE Collaborative Group.
-
Cardiac Troponin Composition Characterization after Non ST-Elevation Myocardial Infarction: Relation with Culprit Artery, Ischemic Time Window, and Severity of InjurySAJ Damen, GE Cramer, H-J Dieker et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
